Skip to content
Research Article Open access CC BY 4.0

Cyclodextrin-Based Delivery of Traditional Chinese Medicine Active Molecules

Lili Cai, Jiajun Chen, Suimei Wei, Suya Huang, Yong-Guang Jia

Organics · pp. 35–35 · Published 7 Aug 2026

10.3390/org7030035

Abstract

Active molecules derived from traditional Chinese medicine (TCM) represent a valuable source of lead compounds for modern drug discovery, demonstrating considerable potential in the prevention and treatment of chronic diseases, cancer therapy, and immune modulation. Nevertheless, their clinical translation is often impeded by intrinsic limitations such as poor aqueous solubility, low bioavailability, inadequate chemical stability, and significant gastrointestinal irritation. Cyclodextrins (CDs) and their derivatives, characterized by a hydrophobic internal cavity, are capable of forming inclusion complexes with TCM and their derived active constituents, thereby improving their physicochemical and pharmacokinetic profiles. Over the past five years, substantial progress has been made in this domain. CD-based inclusion strategies have been shown to markedly enhance the solubility and dissolution rate of poorly water-soluble TCM compounds, including flavonoids, alkaloids, and terpenoids. Moreover, this approach contributes to improved drug stability, effective taste masking, and the achievement of modified release profiles, such as sustained or targeted delivery, ultimately leading to enhanced therapeutic efficacy and reduced adverse effects. The development of novel CD derivatives and smart delivery systems has further broadened their application potential. This review summarizes recent advances in the CD-based encapsulation of TCM active molecules, highlighting key formulation strategies that address persistent challenges in the modernization of TCM. It also provides a foundation for future research and development in natural product-based therapeutics.

Medicine Traditional Chinese medicine Drug delivery Drug Drug development Active ingredient Adverse effect Pharmacology

References (99)

  1. 1 Zhao, 2023, Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi-active components combination [DOI]
  2. 2 Zou, Q., Chen, Y., Qin, H., Tang, R., Han, T., Guo, Z., Zhao, J., and Xu, D. (2023). The role and mechanism of TCM in the prevention and treatment of infectious diseases. Front. Microbiol., 14. [DOI]
  3. 3 Ribeiro, 2015, Proinflammatory Pathways: The Modulation by Flavonoids [DOI]
  4. 4 Ghosh, R., Bryant, D.L., and Farone, A.L. (2020). Panax quinquefolius (North American Ginseng) Polysaccharides as Immunomodulators: Current Research Status and Future Directions. Molecules, 25. [DOI]
  5. 5 Zhai, Z., Niu, J., Xu, L., and Xu, J. (2024). Advanced Application of Polymer Nanocarriers in Delivery of Active Ingredients from Traditional Chinese Medicines. Molecules, 29. [DOI]
  6. 6 Parvin, N., Aslam, M., Joo, S.W., and Mandal, T.K. (2025). Nano-Phytomedicine: Harnessing Plant-Derived Phytochemicals in Nanocarriers for Targeted Human Health Applications. Molecules, 30. [DOI]
  7. 7 Yu, 2012, Enhancement of solubility and dissolution rate of cryptotanshinone, tanshinone I and tanshinone IIA extracted from Salvia miltiorrhiza [DOI]
  8. 8 Kang, C., Wang, J., Li, R., Gong, J., Wang, K., Wang, Y., Wang, Z., He, R., and Li, F. (2023). Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine. Molecules, 28. [DOI]
  9. 9 Musuc, A.M. (2024). Cyclodextrins: Advances in Chemistry, Toxicology, and Multifaceted Applications. Molecules, 29. [DOI]
  10. 10 Nicolaescu, O.E., Ionescu, C., Samide, A., Tigae, C., Spînu, C.I., and Oprea, B. (2025). Advancements in Cyclodextrin Complexes with Bioactive Secondary Metabolites and Their Pharmaceutical Applications. Pharmaceutics, 17. [DOI]
  11. 11 Gerges, 2026, Cyclodextrin-in-Liposome for therapy: Advances and challenges [DOI]
  12. 12 Szejtli, 1998, Introduction and general overview of cyclodextrin chemistry [DOI]
  13. 13 Crini, 2014, Review: A History of Cyclodextrins [DOI]
  14. 14 Liu, 2022, Multicharged cyclodextrin supramolecular assemblies [DOI]
  15. 15 Harada, 2009, Polymeric Rotaxanes [DOI]
  16. 16 Malanga, 2016, “Back to the Future”: A New Look at Hydroxypropyl Beta-Cyclodextrins [DOI]
  17. 17 Stella, 2020, Sulfobutylether-β-cyclodextrin [DOI]
  18. 18 Kali, 2024, Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products [DOI]
  19. 19 Sahoo, 2025, Current Insights into Therapeutic Potential of Terpenoids as Anticancer Agents [DOI]
  20. 20 Li, 2024, Self-assembled nanodrug delivery systems for anti-cancer drugs from traditional Chinese medicine [DOI]
  21. 21 Mai, R., Xue, S., Ren, J., Fan, G., Yang, J., Huang, L., Li, G., Cheng, Y., Wang, Q., and Yang, Y. (2025). Mechanism and Multilayer Perceptron prediction model of the removal of α-terpineol, terpinen-4-ol and carvone from pasteurized citrus juices by β-cyclodextrin encapsulation. Front. Nutr., 12. [DOI]
  22. 22 Wu, K., Zhang, T., Chai, X., Duan, X., He, D., Yu, H., Liu, X., and Tao, Z. (2023). Encapsulation Efficiency and Functional Stability of Cinnamon Essential Oil in Modified β-cyclodextrins: In Vitro and In Silico Evidence. Foods, 12. [DOI]
  23. 23 Ali, 2021, Potential therapeutic applications of phytoconstituents as immunomodulators: Pre-clinical and clinical evidences [DOI]
  24. 24 Liang, 2016, Opioid system modulates the immune function: A review
  25. 25 Xiao, Y., Cui, Y., Zhang, Y., Fu, W., Liu, Y., and Liu, F. (2025). Berberine hydrochloride enhances innate immunity to protect against pathogen infection via p38 MAPK pathway. Front. Immunol., 16. [DOI]
  26. 26 Tisnerat, 2022, Antimalarial drug discovery: From quinine to the most recent promising clinical drug candidates [DOI]
  27. 27 Yu, 2022, The interactions of paclitaxel with tumour microenvironment [DOI]
  28. 28 Ghanbari-Movahed, M., Kaceli, T., Mondal, A., Farzaei, M.H., and Bishayee, A. (2021). Recent advances in improved anticancer efficacies of camptothecin nano-formulations: A systematic review. Biomedicines, 9. [DOI]
  29. 29 Loh, J.S., Tan, L.K.S., Lee, W.L., Ming, L.C., How, C.W., Foo, J.B., Kifli, N., Goh, B.H., and Ong, Y.S. (2021). Do Lipid-Based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?. Cancers, 13. [DOI]
  30. 30 Yang, X. (2025). Molecular Mechanisms of Plant Polyphenols Inhibiting the Formation of Heterocyclic Amines in Roasted Meat. [Ph.D. Thesis, Universite de Liege].
  31. 31 Fantini, 2015, In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: Perspectives on cancer treatment [DOI]
  32. 32 Guo, 2021, Polyphenol-containing nanoparticles: Synthesis, properties, and therapeutic delivery [DOI]
  33. 33 Sarkar, 2023, Micromolar affinity and higher: Synthetic host–guest complexes with high stabilities [DOI]
  34. 34 Prodea, A., Mioc, A., Banciu, C., Trandafirescu, C., Milan, A., Racoviceanu, R., Ghiulai, R., Mioc, M., and Soica, C. (2022). The Role of Cyclodextrins in the Design and Development of Triterpene-Based Therapeutic Agents. Int. J. Mol. Sci., 23. [DOI]
  35. 35 Koyuncu, A., and Ciftci, F. (2025). Role of Weak Interactions and Steric Effect in Chemosensing Using Cyclodextrins. Cyclodextrins for Chemosensing, Springer. [DOI]
  36. 36 Pirvu, A.S., Varut, R.-M., Trasca, D.-M., Stoica, G.A., Radivojevic, K., Carmen, S., Arsenie, C.C., and Popescu, C. (2025). Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients. Pharmaceuticals, 18. [DOI]
  37. 37 Simsek, T., Rasulev, B., Mayer, C., and Simsek, S. (2020). Preparation and characterization of inclusion complexes of β-cyclodextrin and phenolics from wheat bran by combination of experimental and computational techniques. Molecules, 25. [DOI]
  38. 38 Kim, 2020, Study of flavonoid/hydroxypropyl-β-cyclodextrin inclusion complexes by UV-Vis, FT-IR, DSC, and X-Ray diffraction analysis [DOI]
  39. 39 Rajamohan, R., Ashokkumar, S., Murugavel, K., and Lee, Y.R. (2023). Preparation and Characterization of a Nano-Inclusion Complex of Quercetin with β-Cyclodextrin and Its Potential Activity on Cancer Cells. Micromachines, 14. [DOI]
  40. 40 Xu, 2019, Interactions between β-cyclodextrin and tea catechins, and potential anti-osteoclastogenesis activity of the (−)-epigallocatechin-3-gallate–β-cyclodextrin complex [DOI]
  41. 41 Lavania, 2023, Inclusion complex of chrysin with hydroxypropyl-β-cyclodextrin (HP-β-CD) preparation, characterization, and dissolution study [DOI]
  42. 42 Song, 2024, Screening and inclusion of luteolin for β-cyclodextrin: Molecular simulations and experiments [DOI]
  43. 43 Guadarrama, 2023, Inclusion and Non-Inclusion Complexes Between Curcumin and β-Cyclodextrin with High-Curcumin Loading and Enhanced Aqueous Solubility Obtained by Mechanochemistry [DOI]
  44. 44 Catenacci, L., Sorrenti, M., Bonferoni, M.C., Hunt, L., and Caira, M.R. (2020). Inclusion of the Phytoalexin trans-Resveratrol in Native Cyclodextrins: A Thermal, Spectroscopic, and X-Ray Structural Study. Molecules, 25. [DOI]
  45. 45 Mazurek, A.H., and Szeleszczuk, Ł. (2023). A review of applications of solid-state Nuclear Magnetic Resonance (SSNMR) for the analysis of cyclodextrin-including systems. Int. J. Mol. Sci., 24. [DOI]
  46. 46 Betlejewska-Kielak, K., Bednarek, E., Budzianowski, A., Michalska, K., and Maurin, J.K. (2021). Comprehensive characterisation of the ketoprofen-β-cyclodextrin inclusion complex using X-ray techniques and NMR spectroscopy. Molecules, 26. [DOI]
  47. 47 Inoue, 2023, Inclusion complexes of Ursolic acid with Cyclodextrin-based metal-organic Framework-1 enhance its solubility [DOI]
  48. 48 Novac, M., Musuc, A.M., Ozon, E.A., Sarbu, I., Mitu, M.A., Rusu, A., Petrescu, S., Atkinson, I., Gheorghe, D., and Lupuliasa, D. (2022). Design and Evaluation of Orally Dispersible Tablets Containing Amlodipine Inclusion Complexes in Hydroxypropyl-β-cyclodextrin and Methyl-β-cyclodextrin. Materials, 15. [DOI]
  49. 49 Park, 2022, Size compatibility and concentration dependent supramolecular host–guest interactions at interfaces [DOI]
  50. 50 Bouchemal, 2012, How to conduct and interpret ITC experiments accurately for cyclodextrin–guest interactions [DOI]
  51. 51 Gierycz, 2013, Isothermal titration calorimetry (ITC) study of natural cyclodextrins inclusion complexes with drugs [DOI]
  52. 52 Kou, 2024, Supramolecular chemistry in cyclodextrin inclusion complexes: The formation rules of terpenes/β-cyclodextrin inclusion complexes [DOI]
  53. 53 Pagano, 2022, Thermodynamic properties of hydroxypropyl-β-cyclodextrin/guest interaction: A survey of recent studies [DOI]
  54. 54 Liu, 2013, Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex [DOI]
  55. 55 Stergiou, 2022, Host–guest inclusion complexes of hydroxytyrosol with cyclodextrins: Development of a potential functional ingredient for food application [DOI]
  56. 56 Shanmugam, 2019, Inclusion complex with cyclodextrins enhances the bioavailability of flavonoid compounds: A systematic review [DOI]
  57. 57 Shukla, V., Niveria, K., Shashidhar, P., and Verma, A.K. (2023). Dynamic light scattering (DLS) particle size analysis for biomedical nanotechnology. Analytical Techniques for Biomedical Nanotechnology, IOP Publishing. [DOI]
  58. 58 Jarho, 2022, Improved ocular delivery of quercetin and resveratrol: A comparative study between binary and ternary cyclodextrin complexes [DOI]
  59. 59 Mendes, 2015, Quantitative Analysis of Norfloxacin in β-Cyclodextrin Inclusion Complexes—Development and Validation of a Stability-indicating HPLC Method [DOI]
  60. 60 Zhao, G., Tong, Y., Luan, F., Zhu, W., Zhan, C., Qin, T., An, W., and Zeng, N. (2022). Alpinetin: A Review of Its Pharmacology and Pharmacokinetics. Front. Pharmacol., 13. [DOI]
  61. 61 Cheng, K.-W., Chen, F., and Wang, M. (2007). Liquid chromatography-mass spectrometry in natural product research. Bioactive Natural Products, CRC Press. [DOI]
  62. 62 Li, 2025, Encapsulation of oleanolic acid into cyclodextrin metal-organic frameworks by co-crystallization: Preparation, structure characterization and its effect on a zebrafish larva NAFLD model [DOI]
  63. 63 Salvador, 2025, Immunomodulatory Effect of the Ursolic Acid/Poly-β-cyclodextrin Complex in an Experimental Model of Multiple Sclerosis
  64. 64 Fajardo, 2025, Enhanced Antitumor and Antibacterial Activities of Ursolic Acid Through β-Cyclodextrin Inclusion Complexation [DOI]
  65. 65 Alishahi, 2024, Antibacterial, Anti-Inflammatory, and Antioxidant Cotton-Based Wound Dressing Coated with Chitosan/Cyclodextrin–Quercetin Inclusion Complex Nanofibers [DOI]
  66. 66 Kolay, 2025, Investigation of Curcumin-β-cyclodextrin complex release in injectable hyaluronic acid/quince seed gum hydrogel [DOI]
  67. 67 Klojdová, I., Milota, T., Smetanová, J., and Stathopoulos, C. (2023). Encapsulation: A strategy to deliver therapeutics and bioactive compounds?. Pharmaceuticals, 16. [DOI]
  68. 68 Chen, 2024, Sonochemical synthesis of γ-CD-MOFs microcapsule for myricetin delivery: Study of adsorption mechanism, molecular simulation, solubility, antioxidation, biocompatibility, and in vitro digestion [DOI]
  69. 69 Zhang, 2024, Interaction of zein/HP-β-CD nanoparticles with digestive enzymes: Enhancing curcumin bioavailability [DOI]
  70. 70 Pongsamart, 2022, Preparation, characterization and antimalarial activity of dihydroartemisinin/β-cyclodextrin spray-dried powder [DOI]
  71. 71 Niazvand, 2020, An overview of the development of composites containing Mg and Zn for drug delivery
  72. 72 Azari, 2021, The expanding role of CDR1-AS in the regulation and development of cancer and human diseases [DOI]
  73. 73 Cho, 2020, Recent progresses in the development of hyaluronic acid-based nanosystems for tumor-targeted drug delivery and cancer imaging [DOI]
  74. 74 Ghasemzadeh, 2022, Ursolic acid loaded β-cyclodextrin/folic acid/Fe3O4 nanocomplex for drug delivery to tumor cells [DOI]
  75. 75 Jiang, 2025, Design and properties of cyclodextrin grafted chitosan/sodium alginate dual-network hydrogel based on physical cross-linking [DOI]
  76. 76 Jabbari, 2022, Design and synthesis of a star-like polymeric micelle modified with AS1411 aptamer for targeted delivery of camptothecin for cancer therapy [DOI]
  77. 77 Li, 2023, Simultaneous qualitative and quantitative analysis of flavonols in Kaempferia galangal L. and honey by machine learning-based fluorescence sensor array [DOI]
  78. 78 Lin, 2023, pH-responsive double-layer film based on chitosan/curcumin-β-cyclodextrin complex/cinnamaldehyde and zein/alizarin for pork freshness monitoring and maintaining [DOI]
  79. 79 Yang, 2024, Development of dual-channel starch-based film incorporated with betanin@ β-cyclodextrin inclusion complex and berberine for indicating shrimp freshness [DOI]
  80. 80 Hirave, K., Morya, N., Banerjee, S., Singh, A., and Saharan, V.A. (2025). Phytoconstituents and Plant Extract-Based Formulations for Wound Healing. Formulating Pharma-, Nutra-, and Cosmeceutical Products from Herbal Substances: Dosage Forms and Delivery Systems, Wiley. [DOI]
  81. 81 Tolun, 2025, Electrospun nanofibers of curcumin/HP-beta-CD/pullulan complex with enhanced solubility and controlled release in food and drug delivery applications [DOI]
  82. 82 Riascos, 2021, Technological evolution of cyclodextrins in the pharmaceutical field [DOI]
  83. 83 Khanna, 2024, Functionalization of outdoor cotton textiles: Combining fragrance and uv protection through β-cyclodextrin derivative inclusion complexes infused with peppermint and clove essential oils [DOI]
  84. 84 Liu, 2024, Antibacterial effects and mechanisms of quercetin-β-cyclodextrin complex mediated photodynamic on Escherichia coli O157: H7 [DOI]
  85. 85 Ye, 2024, Pickering emulsion stabilized by quercetin-β-cyclodextrin-diglyceride particles: Effect of diglyceride content on interfacial behavior and emulsifying property of complex particles [DOI]
  86. 86 Nagaraj, 2024, Synthesis, characterization, molecular modeling, binding energies of β-cyclodextrin-inclusion complexes of quercetin: Modification of photo physical behavior upon β-CD complexation [DOI]
  87. 87 Maxwell, 2024, A novel In situ gelling system of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan nanoparticles for the treatment of vulvovaginitis [DOI]
  88. 88 Wangsawangrung, N., Choipang, C., Chaiarwut, S., Ekabutr, P., Suwantong, O., Chuysinuan, P., Techasakul, S., and Supaphol, P. (2022). Quercetin/Hydroxypropyl-β-Cyclodextrin inclusion complex-loaded hydrogels for accelerated wound healing. Gels, 8. [DOI]
  89. 89 Hu, 2023, Quercetin inclusion complex gels ameliorate radiation-induced brain injury by regulating gut microbiota [DOI]
  90. 90 Yang, 2025, An injectable hyaluronic acid hydrogel protects against retinal pigment epithelial injury induced by sodium iodate
  91. 91 Zhou, 2024, Inclusion complex of berberine hydrochloride with serine-β-cyclodextrin: Construction, characterization, inclusion mechanisms, and bioactivity [DOI]
  92. 92 Hasan, 2023, Berberine and cyclodextrin based supramolecular assembly for the detection of a cancer biomarker in complex biomatrices via indicator displacement assay [DOI]
  93. 93 Chakraborty, 2022, Supramolecular modulation in photophysical features of berberine and its application towards ATP sensing [DOI]
  94. 94 Liang, 2024, Functionalized hydroxypropyl-β-cyclodextrin derivative as a versatile nanovehicle for delivery of paclitaxel [DOI]
  95. 95 Fu, 2025, Functionalized hydroxypropyl-β-cyclodextrin inclusion complex for combined tumor therapy through intelligent delivery of paclitaxel and polarization of M2-like tumor associated macrophages [DOI]
  96. 96 Velhal, 2025, B-cyclodextrin inclusion complex as a potent delivery system for enhanced cytotoxicity of paclitaxel in triple-negative breast cancer cells [DOI]
  97. 97 Rajendran, 2024, Preparation of β-cyclodextrin conjugated, gelatin stabilized SBA 15-CuInS2/ZnS quantum dot nanocomposites for camptothecin release [DOI]
  98. 98 Schoeman, 2024, Cyclodextrin inclusion complex and amorphous solid dispersions as formulation approaches for enhancement of curcumin’s solubility and nasal epithelial membrane permeation [DOI]
  99. 99 Morchang, 2025, Proteomic analysis reveals a potential anticancer mechanism for a novel effervescent curcumin-ascorbic acid-polysaccharide-β-cyclodextrin inclusion complex towards colorectal cancer cells through modulation of ribosome biogenesis

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.